Sompo, a leading commercial insurance provider in Japan, has entered a partnership with Israeli telehealth startup TytoCare to introduce its artificial intelligence-based remote medical device for elderly nursing care services.
According to a Times of Israel report, under a recent commercial collaboration agreement with Sompo’s digital arm, Light Vortex, TytoCare will integrate its remote medical examination products into nursing homes and the elderly care market throughout Japan. This partnership follows the regulatory approval of TytoCare’s products by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
Sompo has been active in Israel through its Digital Lab Tel Aviv since 2018, investing over $20 million in Israeli startups, including companies like Nexar (smart car dashcams), Intuition Robotics (robotics development), and Binah.ai (health data platform).
Sompo’s nursing care business operates the largest chain of nursing homes for the elderly in Japan, with 301 nursing homes comprising 28,500 rooms, along with 58-day centres for the elderly and 505 centres offering various services for the aging population.
TytoCare, founded in 2012 and headquartered in Netanya, Israel, has developed an FDA-cleared handheld remote medical examination device that replicates a doctor’s office in the comfort of one’s home. This smart clinic device includes attachments for examining the heart, lungs, skin, ears, throat, abdomen, and measuring body temperature, enabling users to conduct comprehensive physical examinations.
Sompo Digital Lab Tel Aviv head Yinnon Dolev described the collaboration’s goal as upgrading elderly care through TytoCare’s innovative remote medicine solution, which includes a diagnostic camera, digital stethoscope, and an AI-based clinical insights module to assist doctors in diagnosis.
“The purpose of the collaboration is to produce optimal data-based medical care, in places where the medical staff is not physically present,” Dolev said.
Likewise, TytoCare CEO Dedi Gilad said that the collaboration combines advanced telemedicine solutions with the Japanese insurer’s commitment to making healthcare services accessible within the wider market in the country.
“We believe that in the end we can together improve the well-being of the community and set new standards for the quality and convenience of medicine in Japan in general,” Gilad said.
What are your thoughts on this story? Please feel free to share your comments below.
